Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Cystic Fibrosis Therapeutics Market

Cystic Fibrosis Therapeutics Market Share

Report ID: GMI5118
Published Date: Sep 2021
Report Format: PDF

Download Free Sample

Cystic Fibrosis Therapeutics Market Share

Some of the prominent companies operating in the market are:

Vertex Pharmaceutical Incorporated
Roche
Nestle Health Science
AbbVie
Viatris Inc.
Horizon Therapeutic Plc.
Gilead Sciences
Chiesi Farmacrutici
Pharmaxis Ltd.
Teva Pharmaceuticals.

These market participants are implementing various growth strategies to sustain the industry competition.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global cystic fibrosis therapeutics market size was over USD 8.5 billion during 2020 and is anticipated to register about 16.1% CAGR over 2021-2027.

Medications held nearly USD 6.1 billion share of global cystic fibrosis therapeutics industry in 2020 with increasing demand for mucus thinner, bronchodilators, bronchodilators and other products.

Hospitals are expected to account for almost 49% of cystic fibrosis therapeutics consumption by 2027, with the demand for precise diagnosis and treatments by experienced medical professionals.

North America held around 76% of cystic fibrosis therapeutics industry share during 2020 and the share will expand with high prevalence of the disorder and wider availability of treatment options in the region.

Major companies offering cystic fibrosis therapeutic products worldwide include AbbVie, Gilead Sciences, Roche, Pharmaxis Ltd., Nestle Health Science, and Vertex Pharmaceutical Incorporated, among others.